Home Biosimilar Antibodies Others Others antibody Azintuxizumab (Anti-SLAMF7 / CS1) For research use only.
Not for use in humans.

Azintuxizumab (Anti-SLAMF7 / CS1)

Synonyms: ABBV-383

Azintuxizumab (Anti-SLAMF7 / CS1) is a monoclonal IgG4 bispecific antibody targeting B-cell maturation antigen (BCMA). It has the potential for the research of relapsed/refractory multiple myeloma (RRMM). MW :140.12 KD.

Azintuxizumab (Anti-SLAMF7 / CS1)

Purity & Quality Control

≥99

Biological Activity

Description Azintuxizumab (Anti-SLAMF7 / CS1) is a monoclonal IgG4 bispecific antibody targeting B-cell maturation antigen (BCMA). It has the potential for the research of relapsed/refractory multiple myeloma (RRMM). MW :140.12 KD.

Product Details

CAS No. 1826819-57-1
Isotype Human IgG1
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Azintuxizumab (Anti-SLAMF7 / CS1) | Azintuxizumab (Anti-SLAMF7 / CS1) supplier | purchase Azintuxizumab (Anti-SLAMF7 / CS1) | Azintuxizumab (Anti-SLAMF7 / CS1) cost | Azintuxizumab (Anti-SLAMF7 / CS1) manufacturer | order Azintuxizumab (Anti-SLAMF7 / CS1) | Azintuxizumab (Anti-SLAMF7 / CS1) distributor